Michael Naill

Michael Naill currently serves as Senior Vice President of Product and Process Development at Merida Biosciences since April 2024. Prior to this role, Michael held multiple positions at Dragonfly Therapeutics, Inc., including Senior Vice President, Vice President, and Senior Director of CMC Technical Operations from May 2018 to March 2024. Earlier experience includes a Director role in Manufacturing Sciences and an Associate Director role in CMC Regulatory Science at bluebird bio and AbbVie, respectively. Michael began professional career as a Senior Scientist in Technical Operations at Abbott Laboratories. Academic qualifications include a Ph.D. in Chemical Engineering from the University of Massachusetts Amherst and a Bachelor of Science in Chemical Engineering from the University of Illinois Urbana-Champaign.